About Us

Strategic intelligence for the radiation healthcare
Bringing value to businesses and investors!
MEDraysintell is a team of international experts providing first-rate strategic intelligence in nuclear medicine, radiotherapy, proton therapy and brachytherapy.

We offer the most comprehensive set of reports and directories, with over 2,100 pages of unrivaled intelligence covering some of the most exciting healthcare technologies using radiation for diagnosis and treatment.

We offer client-specific intelligence in the field of radiation healthcare, with the upmost knowledge leveraging our extended network of worldwide contacts.

We are proud to support numerous companies globally, helping them better understand the markets, competitive environment as well as the potential of merger and acquisitions (M&A) and technology development. We have repeat satisfied clients operating in the field of medical radiation, investment banks and institutional investors, large international consulting firms and universities research laboratories.

MEDraysintell was created in 2013 by Paul-Emmanuel Goethals and Richard Zimmermann. It combines over 70 years of experience in radiation healthcare.

 

The Team

The partners & co-authors of MEDraysintell combine more than 70 years of experience in radiotherapy, particle therapy and nuclear medicine.
 
Paul-Emmanuel GOETHALS, MBA

Co-founder, Partner

Phone: +32 491 080 968
peg@medraysintell.com

Paul-Emmanuel Goethals founded CSIntell in 2012 followed by MEDraysintell in 2013. He has 29 years of experience in consulting, business development-intelligence and investor relations with a unique understanding of the medical and healthcare markets, especially in Radiotherapy, Radiopharmacy. Throughout these years he made numerous reports on complex markets as well as outstanding company profiles at the full satisfaction of his successive clients.

Paul-Emmanuel holds an MBA from the University of Dallas and is a member of SCIP (Strategic and Competitive Intelligence Professionals, Virginia, USA) and of MIFB (Market Intelligence Forum Belgium).

Prior founding MEDraysintell and CSIntell, Paul-Emmanuel was Vice President Business Development & Capital Markets and Special Counsel to the CEO at Eckert & Ziegler Group, a European group listed in Frankfurt and Brussels, active in cancer therapy, radiometry, nuclear-medical imaging (2009-2012); Director Corporate Business Development & Investor Relations at IBA, a Belgian company listed in Brussels, active in Proton Therapy, Radiopharmacy, Dosimetry and Industrial Sterilization (1998-2009); Project Manager at Strategic Analysis Inc., a US management consulting firm active in Chemical and Pharmaceutical Business Intelligence (1994 - 1998); Finance Director & Board member at Evening Group SA, a Belgian company active in business events (1992-1993) and Marketing Specialist & Product Management at Chemviron Carbon, the European branch of a US chemical group (1989-1992).

Dr. Richard ZIMMERMANN

Co-founder, Partner

Phone: +33 6 82 80 06 00
rz@medraysintell.com

Dr. Richard Zimmermann founded Chrysalium Consulting in 2012 and MEDraysintell in 2013. He is a chemistry engineer, with a PhD degree in organic chemistry obtained in 1984 from the University of Strasbourg, France followed by a post-doctoral at Georgetown University, Washington, DC. He has over 30 years of experience in research laboratories of conventional pharmaceutical companies (Beecham, Solvay Pharmaceuticals) in France, Germany and the Netherlands, further as head of the Research and Development team at CIS bio International (acquired by IBA in 2006), then he became in charge of the radiopharmaceutical business development at IBA, to create the nuclear medicine product pipeline of the company.

With Chrysalium Consulting, Richard Zimmermann helps companies in the field of medical applications using radiations, mainly in nuclear medicine (radiopharmaceuticals) with a main focus on business development (evaluation, competition analysis, strategic development, pipeline management) and translational processes (industrialization processes, regulatory constraints and clinical development). He is also founder and president of the Oncidium foundation, aiming at promoting and developing radiotherapeutics www.oncidium-life.org.

Serge Goossens

Co-author & Advisor


s.goossens@deliveran.be

Serge Goossens has an extended experience in transport and logistic of medical isotopes in Europe and the US. Prior joining MEDraysintell as co-author and advisor, he was the CEO, until September 2017, of Isotopes Services International, a company he founded in 1988 in Belgium. He also co-founded ISOVital in France; both companies are active in the international distribution of radioactive isotopes for the pharmaceutical market.

Serge was also the president of EITA (European Isotopes Transport Association) until March 2018, a non-profit association focusing on transport and handling of radioactive isotopes, which he co-founded in 1998.

He co-organized the Symposiums on Medical Isotopes (Belgium) and was an active member of AIPES (Association of Imaging Producers & Equipment Suppliers) transport working group until 2018.

MEDraysintell is a member of Rad4Med.be, the Belgian Network for Radiation Applications in Healthcare.

Our Office

For general enquiry please e-mail to: contact@medraysintell.com


Paul-Emmanuel Goethals, MBA
Louvain-la-Neuve, Belgium
Phone: +32 491 080 968
peg@medraysintell.com


Dr. Richard Zimmermann, PhD
Lalaye, France
Phone: +33 6 82 80 06 00
rz@medraysintell.com

 

© Copyright 2018  MEDraysintell